Fasting level Post-prandial response1
  Atazanavir/Ritonavir (SE) Darunavir/Ritonavir (SE) p Atazanavir/Ritonavir (SE) Darunavir/Ritonavir (SE) p
Triglycerides +0.4 mmol/L (0.1) +0.2 mmol/L (0.2) 0.545 +0.3 mmolh/L (0.4) -0.4 mmolh/L (0.4) 0.244
Total cholesterol +0.3 mmol/L (0.1) +0.8 mmol/L (0.2) 0.041 -0.1 mmolh/L (0.1) -0.3 mmolh/L (0.2) 0.270
Low-density lipoprotein cholesterol +0.1 mmol/L (0.1) +0.7 mmol/L (0.2) 0.017 -0.3 mmolh/L(0.2) +0.2 mmolh/L (0.3) 0.276
High-density lipoprotein cholesterol 0.0 mmol/L (0.0) +0.1 mmol/L (0.0) 0.495 -0.1 mmolh/L (0.2) -0.5 mmolh/L (0.2) 0.239
Total:Low-density lipoprotein +0.1 (0.2) +0.4 (0.2) 0.174 <0.1 (0.5) +0.9 (0.7) 0.299
Glucose +0.2 mmol/L (0.1) -0.2 mmol/L (0.2) 0.120 -0.3 mmolh/L (0.6) +0.3 mmolh/L (0.8) 0.554
C-reactive protein -0.2 mg/L (1.1) -0.9 mg/L (0.6) 0.805 +1.2 mgh/L (0.6) +0.6 mgh/L (0.7) 0.473
D-dimer <0.1 mg/L (0.1) <0.1 mg/L (0.1) 0.190 <0.1 mgh/L (0.1) +0.3 mgh/L (0.5) 0.518
Arterial stiffness +2.2 % (4.2) +0.2 % (2.4) 0.670 -27.6 h% (11.6) +0.1 h% (4.7) 0.041
SE: standard error of the mean
Table 2: Mean post-prandial changes between baseline and week 4, measured as incremental area under the curve.